REVIEW
Add like
Add dislike
Add to saved papers

Blindness following cosmetic blepharoplasty--a review.

A case of unilateral blindness following cosmetic blepharoplasty is reported. A review of some 60 previously recorded cases is made with a more detailed analysis of 22 cases. An attempt has been made to highlight the opinions on causes and treatment held in common by those authors who have previously reported and discussed their cases. A degree of retrobulbar haemorrhage was a feature common to most cases and the final event leading to permanent visual impairment was usually ischaemia of retinal or optic nerve tissue. The relationship between these findings remains uncertain although intra-orbital compression was thought to be a frequent common pathway. Recommendations to reduce the chance of this rare but serious complication are made. The importance of simple pre-operative eye records and the early involvement of an ophthalmic surgeon when retrobulbar haemorrhage arises are stressed.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app